Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Atea Pharmaceuticals, Inc. | Director | Common Stock | 65.6K | $229K | $3.49 | Jun 20, 2024 | Direct |
Atea Pharmaceuticals, Inc. | Director | Restricted Stock Units | 29.6K | $118K | $4.00 | Jun 21, 2024 | Direct |
Atea Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 41.2K | Jun 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVIR | Atea Pharmaceuticals, Inc. | Jun 20, 2024 | 3 | -$61.1K | 4 | Jun 21, 2024 | Director |
AVIR | Atea Pharmaceuticals, Inc. | Jun 16, 2024 | 2 | $0 | 4 | Jun 18, 2024 | Director |
AVIR | Atea Pharmaceuticals, Inc. | Jun 16, 2023 | 2 | $0 | 4 | Jun 21, 2023 | Director |
AVIR | Atea Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
AVIR | Atea Pharmaceuticals, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |